INDUSTRY TRENDS: BY THE NUMBERS Compiled by Cari Kraft, Jacobs Management Group, Inc.
258
Number of vaccines under development for many conditions. Industry organization PhRMA reports that 258 vaccines are in development in the US, including 108 for cancer, 125 for infectious diseases, 14 for allergies, and two for Alzheimer’s disease. Additionally, there are more than 70 for Covid-19 in the global research pipeline, including six now in human clinical trials. Source: PhRMA, Biopharmaceutical Companies are Researching and Developing Nearly 260 Vaccines, April 2020
15
Number of countries that ship 86% of all drugs Only 15 countries are producing and exporting 86.2% of all medicines, according to 2019 figures. Germany (14.5%), Switzerland (12.2%), The Netherlands (7.9%), Belgium (7.4%), France (6.8%) and Italy (6.3%) all lead the US, which exports 6.2%, valued at $24.3B. Fastest growing are Denmark, Netherlands, Italy and Switzerland. Source: World’s Top Experts, Drugs and Medicine Exports by Country, August, 2020
48
Number of novelty drugs approved by CDER in 2019 The Center for Drug Evaluation and Research (CDER), an FDA-regulated division that deals with drug approvals, approved a record number of novelty drugs in 2019. Novelty drugs are new molecular entities that have the potential to treat diseases with a new pharmacological mechanism. Twenty of these products are considered first-in-class drugs. Some of the new medicines treat conditions such as postpartum depression (brexanolone), or metastatic bladder cancer (erdafitinib). Source: FDA, New Drug Approvals 2019, January 2020 43 | HS&M SEPTEMBER/OCTOBER 2020
